Cargando…

Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State

BACKGROUND: Adult-onset neurodegenerative diseases affect millions and negatively impact health care systems worldwide. Evidence suggests that air pollution may contribute to aggravation of neurodegeneration, but studies have been limited. OBJECTIVE: We examined the potential association between lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunez, Yanelli, Boehme, Amelia K., Weisskopf, Marc G., Re, Diane B., Navas-Acien, Ana, van Donkelaar, Aaron, Martin, Randall V., Kioumourtzoglou, Marianthi-Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869948/
https://www.ncbi.nlm.nih.gov/pubmed/33555200
http://dx.doi.org/10.1289/EHP7425
_version_ 1783648715738710016
author Nunez, Yanelli
Boehme, Amelia K.
Weisskopf, Marc G.
Re, Diane B.
Navas-Acien, Ana
van Donkelaar, Aaron
Martin, Randall V.
Kioumourtzoglou, Marianthi-Anna
author_facet Nunez, Yanelli
Boehme, Amelia K.
Weisskopf, Marc G.
Re, Diane B.
Navas-Acien, Ana
van Donkelaar, Aaron
Martin, Randall V.
Kioumourtzoglou, Marianthi-Anna
author_sort Nunez, Yanelli
collection PubMed
description BACKGROUND: Adult-onset neurodegenerative diseases affect millions and negatively impact health care systems worldwide. Evidence suggests that air pollution may contribute to aggravation of neurodegeneration, but studies have been limited. OBJECTIVE: We examined the potential association between long-term exposure to particulate matter [Formula: see text] in aerodynamic diameter [fine particulate matter ([Formula: see text])] and disease aggravation in Alzheimer’s (AD) and Parkinson’s (PD) diseases and amyotrophic lateral sclerosis (ALS), using first hospitalization as a surrogate of clinical aggravation. METHODS: We used data from the New York Department of Health Statewide Planning and Research Cooperative System (SPARCS 2000–2014) to construct annual county counts of first hospitalizations with a diagnosis of AD, PD, or ALS (total, urbanicity-, sex-, and age-stratified). We used annual [Formula: see text] concentrations estimated by a prediction model at a [Formula: see text] resolution, which we aggregated to population-weighted county averages to assign exposure to cases based on county of residence. We used outcome-specific mixed quasi-Poisson models with county-specific random intercepts to estimate rate ratios (RRs) for a 1-y [Formula: see text] exposure. We allowed for nonlinear exposure–outcome relationships using penalized splines and accounted for potential confounders. RESULTS: We found a positive nonlinear [Formula: see text] association that plateaued above [Formula: see text] ([Formula: see text] , 95% CI: 1.04, 1.14 for a [Formula: see text] increase from 8.1 to [Formula: see text]). We also found a linear [Formula: see text] positive association ([Formula: see text] , 95% CI: 1.01, 1.09 per [Formula: see text] [Formula: see text] increase), and suggestive evidence of an association with AD. We found effect modification by age for PD and ALS with a stronger positive association in patients [Formula: see text] of age but found insufficient evidence of effect modification by sex or urbanization level for any of the outcomes. CONCLUSION: Our findings suggest that annual increase in county-level [Formula: see text] concentrations may contribute to clinical aggravation of PD and ALS. Importantly, the average annual [Formula: see text] concentration in our study was [Formula: see text] , below the current American national standards, suggesting the standards may not adequately protect the aging population. https://doi.org/10.1289/EHP7425
format Online
Article
Text
id pubmed-7869948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-78699482021-02-17 Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State Nunez, Yanelli Boehme, Amelia K. Weisskopf, Marc G. Re, Diane B. Navas-Acien, Ana van Donkelaar, Aaron Martin, Randall V. Kioumourtzoglou, Marianthi-Anna Environ Health Perspect Research BACKGROUND: Adult-onset neurodegenerative diseases affect millions and negatively impact health care systems worldwide. Evidence suggests that air pollution may contribute to aggravation of neurodegeneration, but studies have been limited. OBJECTIVE: We examined the potential association between long-term exposure to particulate matter [Formula: see text] in aerodynamic diameter [fine particulate matter ([Formula: see text])] and disease aggravation in Alzheimer’s (AD) and Parkinson’s (PD) diseases and amyotrophic lateral sclerosis (ALS), using first hospitalization as a surrogate of clinical aggravation. METHODS: We used data from the New York Department of Health Statewide Planning and Research Cooperative System (SPARCS 2000–2014) to construct annual county counts of first hospitalizations with a diagnosis of AD, PD, or ALS (total, urbanicity-, sex-, and age-stratified). We used annual [Formula: see text] concentrations estimated by a prediction model at a [Formula: see text] resolution, which we aggregated to population-weighted county averages to assign exposure to cases based on county of residence. We used outcome-specific mixed quasi-Poisson models with county-specific random intercepts to estimate rate ratios (RRs) for a 1-y [Formula: see text] exposure. We allowed for nonlinear exposure–outcome relationships using penalized splines and accounted for potential confounders. RESULTS: We found a positive nonlinear [Formula: see text] association that plateaued above [Formula: see text] ([Formula: see text] , 95% CI: 1.04, 1.14 for a [Formula: see text] increase from 8.1 to [Formula: see text]). We also found a linear [Formula: see text] positive association ([Formula: see text] , 95% CI: 1.01, 1.09 per [Formula: see text] [Formula: see text] increase), and suggestive evidence of an association with AD. We found effect modification by age for PD and ALS with a stronger positive association in patients [Formula: see text] of age but found insufficient evidence of effect modification by sex or urbanization level for any of the outcomes. CONCLUSION: Our findings suggest that annual increase in county-level [Formula: see text] concentrations may contribute to clinical aggravation of PD and ALS. Importantly, the average annual [Formula: see text] concentration in our study was [Formula: see text] , below the current American national standards, suggesting the standards may not adequately protect the aging population. https://doi.org/10.1289/EHP7425 Environmental Health Perspectives 2021-02-08 /pmc/articles/PMC7869948/ /pubmed/33555200 http://dx.doi.org/10.1289/EHP7425 Text en https://ehp.niehs.nih.gov/about-ehp/license EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Research
Nunez, Yanelli
Boehme, Amelia K.
Weisskopf, Marc G.
Re, Diane B.
Navas-Acien, Ana
van Donkelaar, Aaron
Martin, Randall V.
Kioumourtzoglou, Marianthi-Anna
Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
title Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
title_full Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
title_fullStr Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
title_full_unstemmed Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
title_short Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
title_sort fine particle exposure and clinical aggravation in neurodegenerative diseases in new york state
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869948/
https://www.ncbi.nlm.nih.gov/pubmed/33555200
http://dx.doi.org/10.1289/EHP7425
work_keys_str_mv AT nunezyanelli fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT boehmeameliak fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT weisskopfmarcg fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT redianeb fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT navasacienana fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT vandonkelaaraaron fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT martinrandallv fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate
AT kioumourtzogloumarianthianna fineparticleexposureandclinicalaggravationinneurodegenerativediseasesinnewyorkstate